Medtronic

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Medtronic 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDT

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. 

CEO
Geoffrey Straub Martha
CEOGeoffrey Straub Martha
Employees
95,000
Employees95,000
Headquarters
Galway, Galway
HeadquartersGalway, Galway
Founded
2014
Founded2014
Employees
95,000
Employees95,000

MDT Key Statistics

Market cap
121.13B
Market cap121.13B
Price-Earnings ratio
25.80
Price-Earnings ratio25.80
Dividend yield
3.01%
Dividend yield3.01%
Average volume
6.17M
Average volume6.17M
High today
$95.54
High today$95.54
Low today
$93.30
Low today$93.30
Open price
$93.70
Open price$93.70
Volume
3.99M
Volume3.99M
52 Week high
$96.25
52 Week high$96.25
52 Week low
$79.29
52 Week low$79.29

MDT News

Seeking Alpha 13h
Medtronic prices $1.5 billion senior notes

Healthcare Medtronic prices $1.5 billion senior notes Sep. 16, 2025 2:41 AM ET Medtronic plc (MDT) Stock By: Manshi Mamtora, CFA 5 Share Save Play ( 1min ) C...

Medtronic prices $1.5 billion senior notes
Simply Wall St 1d
Medtronic Launches Global Study On Novel Heart Failure Treatment

has recently initiated the ELEVATE-HFpEF study focusing on heart failure treatment, which, alongside other product developments and strategic initiatives, coinc...

Medtronic Launches Global Study On Novel Heart Failure Treatment
TipRanks 1d
Medtronic initiates global pivotal study of cardiac pacing

Medtronic (MDT) announced the initiation of a pivotal study evaluating the use of elevated and personalized cardiac pacing rates for the treatment of patients w...

Analyst ratings

50%

of 34 ratings
Buy
50%
Hold
47.1%
Sell
2.9%

More MDT News

TipRanks 6d
Medtronic’s Strategic Growth Focus and Portfolio Optimization Drive Buy Rating

Morgan Stanley analyst Patrick Wood maintained a Buy rating on Medtronic yesterday and set a price target of $107.00. Elevate Your Investing Strategy: Take adva...

People also own

Based on the portfolios of people who own MDT. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.